Cargando…
Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure
BACKGROUND: Heart failure (HF) is a common disease with complex pathophysiological causes. The diagnosis of HF commonly relies on comprehensive analyses of medical history and symptoms, and results from echocardiography and biochemical tests. Galectin-3, a relatively new biomarker in HF, was approve...
Autores principales: | Yin, Qiu-Sheng, Shi, Bing, Dong, Lan, Bi, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981988/ https://www.ncbi.nlm.nih.gov/pubmed/24748886 http://dx.doi.org/10.3969/j.issn.1671-5411.2014.01.014 |
Ejemplares similares
-
Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
por: Wu, Alan H.B.
Publicado: (2012) -
The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure †
por: Testa, Marzia, et al.
Publicado: (2018) -
Role of galectin-3 and plasma B type-natriuretic peptide in predicting prognosis in discharged chronic heart failure patients
por: Feola, Mauro, et al.
Publicado: (2016) -
Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018) -
Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)